Champions Oncology (CSBR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for October 16, 2025, at 9:00 a.m. in Hackensack, New Jersey.
Shareholders will vote on director elections, auditor ratification, executive compensation, and other business.
Record date for voting eligibility is August 22, 2025.
Voting matters and shareholder proposals
Election of seven Board of Director nominees for the ensuing year.
Ratification of EisnerAmper LLP as independent registered public accounting firm for fiscal year ending April 30, 2026.
Advisory vote on executive compensation for named executive officers.
Other business may be transacted as properly brought before the meeting.
Board of directors and corporate governance
Seven director nominees are up for election to serve until successors are elected and qualified or until earlier death, resignation, or removal.
Latest events from Champions Oncology
- Record study service revenue and positive adjusted EBITDA, with margin improvement expected.CSBR
Q3 202612 Mar 2026 - Q1 revenue was $14.0M, with margin pressure, net loss, and positive cash flow from operations.CSBR
Q1 20263 Feb 2026 - Q4 revenue up 7% and adjusted EBITDA positive, signaling improved outlook.CSBR
Q4 20243 Feb 2026 - Revenue up 12% and return to profitability, but liquidity and going concern risks remain.CSBR
Q1 202520 Jan 2026 - Q2 revenue up 17% to $13.5M, with margin gains and new data licensing amid liquidity risks.CSBR
Q2 202511 Jan 2026 - Record revenue and net income driven by data licensing and operational efficiency.CSBR
Q3 202526 Dec 2025 - Quarterly revenue up 11–11.5% to $15M, margin at 52%, and adjusted EBITDA near $843K.CSBR
Q2 202615 Dec 2025 - Annual meeting to elect directors, ratify auditor, and approve executive pay on advisory basis.CSBR
Proxy Filing1 Dec 2025 - Annual meeting to elect directors, ratify auditor, and approve executive pay, with strong governance.CSBR
Proxy Filing1 Dec 2025